Key Takeaway: Skye Bioscience has announced the use of Arecor's Arestat technology to enhance drug dosing. This development was published on January 4, 2026. The article does not provide further details on the implications or applications of this technology in drug development.
Price reaction · baseline $0.8782 (2026-01-02 close) · 3 other SKYE headline(s) in the window, move may be shared
day 0 close
-2.3%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice